SEOUL, Oct 25 (Reuters) - South Korea will donate 1 million
doses of AstraZeneca's COVID-19 vaccine to Iran, the
Korea Disease Control and Prevention Agency said on Monday.
(Reporting by Sangmi Cha; Editing by Giles Elgood)
Mon, 25th Oct 2021 08:46
SEOUL, Oct 25 (Reuters) - South Korea will donate 1 million
doses of AstraZeneca's COVID-19 vaccine to Iran, the
Korea Disease Control and Prevention Agency said on Monday.
(Reporting by Sangmi Cha; Editing by Giles Elgood)
(Alliance News) - A new treatment for infant respiratory syncytial virus, RSV, – a leading cause of severe illness in US babies – is 90% effective in preventing hospitalization, health authorities said Thursday.
Read more(Alliance News) - A cut to national insurance, stamp duty relief as well as a freeze on fuel and alcohol duties were among the marquee tax measures that UK Chancellor Jeremy Hunt announced in his budget on Wednesday.
Read more(Alliance News) - A treatment that extends the life of people with advanced breast cancer has been blocked for NHS use in England in a move that potentially impacts thousands of patients.
Read more(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Monday said that the European Medicines Agency has approved two marketing authorisation applications for their datopotamab deruxtecan in two types of cancer.
Read more(Sharecast News) - European regulators have validated two marketing authorisation applications (MMAs) for AstraZeneca, as the biopharma giant's datopotamab deruxtecan chemotherapy replacement treatment comes one step closer to receiving the green light to treat two types of cancer.
Read more(Alliance News) - AstraZeneca on Monday announced further support from regulators for its first-in-class blood disease treatment.
Read more(Sharecast News) - European regulators has given the green light to AstraZeneca's blood-disorder drug Voydeya, the biopharma giant announced on Monday.
Read more(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and Thursday and not separately reported by Alliance News:
Read more(Sharecast News) - Drugmaker AstraZeneca revealed late on Monday afternoon that it had successfully completed its acquisition of US-based biopharmaceutical company Icosavax.
Read more(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:
Read more(Alliance News) - European markets lacked direction on Monday, after a quiet day as the US markets celebrated George Washington's birthday.
Read more(Sharecast News) - London's financial markets finished in positive territory on Monday, with stocks closing in the green after overcoming minor losses earlier in the session.
Read more(Alliance News) - AstraZeneca PLC on Monday said it has completed the acquisition of Icosavax Inc.
Read more(Alliance News) - Stock prices in London lacked direction at midday Monday, amid a quiet start to the week.
Read more(Alliance News) - Stock prices in London were looking for direction early Monday, as investors weighed possible trajectories for US interest rate cuts and a China's economic recovery.
Read more